India  

COVID-19 vaccine: Serum Institute seeks emergency use authorisation for Covishield in India

DNA Monday, 7 December 2020
The Serum Institute of India is the second company with a COVID-19 vaccine candidate to seek emergency use authorisation from the DCGI in India.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News

Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News 01:22

After American firm Pfizer sought approval from the drug regulator, Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford...

You Might Like


💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes
India gifts one lakh doses of COVID-19 vaccine to Nepal Army [Video]

India gifts one lakh doses of COVID-19 vaccine to Nepal Army

As a mark of friendship and strong ties between New Delhi and Kathmandu, India gifted one lakh doses of COVID-19 vaccines to the Nepal Army on March 28. The nine packages of Covishield vaccines, manufactured by the Serum Institute of India (SII) arrived in Kathmandu, via an Air India flight late in the evening. So far, India has provided COVID-19 vaccines to over 70 countries. India has also provided medical supplies to 150 nations in the fight during pandemic.

Credit: ANI    Duration: 01:23Published
India-made vaccine to be dispatched for Denmark [Video]

India-made vaccine to be dispatched for Denmark

A consignment of Covishield vaccine, by Serum Institute of India, to be dispatched from Mumbai's Chhatrapati Shivaji Maharaj International Airport to Denmark's Copenhagen as part of the 'Vaccine Maitri' initiative. The consignment will be loaded in A Qatar airways' flight to Doha scheduled to depart at 9.15 am on March 27. So far, India has provided COVID-19 vaccines to over 70 countries. India has also supplied medical supplies to 150 nations in the fight against pandemic.

Credit: ANI    Duration: 01:25Published
Watch: UK PM Boris Johnson gets his first jab of AstraZeneca Covid-19 vaccine [Video]

Watch: UK PM Boris Johnson gets his first jab of AstraZeneca Covid-19 vaccine

British PM Boris Johnson received his first dose of AstraZeneca's Covid vaccine on Friday. The 56-year-old UK PM took to Twitter and shared a video urging the public to do the same. Johnson received the jab at Gassiot House Outpatient Centre in London's St Thomas' Hospital. Last year, Johnson was diagnosed with Covid and was admitted to the hospital for treatment. Johnson had spent a week at St Thomas' Hospital including three days in intensive care. AstraZeneca's jab, developed with Oxford, provides the bulk of Britain's inoculation campaign. A large portion of its supply has also been produced by the Serum Institute of India.

Credit: HT Digital Content    Duration: 02:03Published

Drugs Controller General of India Drugs Controller General of India

Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

The Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines..
IndiaTimes

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for..
IndiaTimes

Sputnik V cleared for launch in India: Five things you need to know about Russian vaccine

Following the recommendation of the Drug Controller General of India (DGCI)'s subject expert committee, Russia's anti-Covid vaccine Sputnik V now awaits final..
IndiaTimes

Expert panel clears Sputnik V for ‘emergency use’, drug regulator’s nod expected soon

Amid concerns about the need to step up Covid-19 vaccination, India is soon expected to get its third shot against the infection with the drug regulator’s..
IndiaTimes

Russia hopes approval to Sputnik-V vaccine by DCGI will be completed soon

Russia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it..
IndiaTimes

Related videos from verified sources

Oxford-AstraZeneca vaccine approved for use in the U.K. [Video]

Oxford-AstraZeneca vaccine approved for use in the U.K.

The Oxford-AstraZeneca vaccine has finally been approved for use in the U.K., giving hope to millions of people.

Credit: Cover Video STUDIO     Duration: 01:12Published
Oxford Covid-19 vaccine approved for UK use [Video]

Oxford Covid-19 vaccine approved for UK use

A Covid-19 vaccine from Oxford University and AstraZeneca has been approvedfor use in the UK, paving the way for rapid rollout, the Department of Healthsaid.

Credit: PA - Press Association STUDIO     Duration: 00:53Published
Covid new strain: How India is preparing to tackle UK & variants of virus [Video]

Covid new strain: How India is preparing to tackle UK & variants of virus

COVID-19 vaccines will work against new variants of the virus and there is no evidence that current vaccines will fail to protect against the SARS-CoV-2 mutants reported from the UK or South Africa,..

Credit: HT Digital Content     Duration: 07:51Published

Related news from verified sources

Reaction in volunteer not linked to COVID-19 vaccine: Drug Authority

A probe initiated by the Drugs Controller General of India (DCGI) into an alleged "serious adverse event" reportedly suffered by an Oxford COVID-19 vaccine trial...
Mid-Day Also reported by •IndiaTimes

COVID-19 vaccine: India will have a happy New Year with something in hand, says DCGI

As India awaits with bated breath for a silver bullet against coronavirus, the Drug Controller General of India (DCGI) on Thursday hinted at the approval of...
Mid-Day Also reported by •Zee News

DCGI seeking more data for granting emergency use authorisation won’t impact timeline for vaccine roll-out: Govt

The vaccine manufacturers during this phase monitor and track the effects of the vaccine systematically after it has been passed.
Hindu Also reported by •IndiaTimesDNA